Risk Factors Analysis for Acute Myocardial Infarction Patients

• Conditions: AMI - Acute Mesenteric Ischemia; Extracorporeal Membrane Oxygenation Complication
• Interventions: Other: Not application

• Registration Number: NCT05390658
• Lead Sponsor: Genglong Liu

Brief Summary

ECMO has been used to save the lives of many critically ill patients with cardiorespiratory dysfunction as important rescue therapy. Though the proportion of ECMO applied to this population has been increasing year by year, clinical outcomes of AMI remain poor with high in-hospital mortality. Thus, it is necessary to characterize clinical features and investigate potentially modifiable factors contributing to outcomes of AMI patients who received ECMO treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-11
• Status Verified: 2022-05
• Study First Submitted: 2022-05-16
• Study First Submitted QC: 2022-05-19
• Last Update Submitted: 2022-05-19
• Study First Posted: 2022-05-25
• Last Update Posted: 2022-05-25
• Primary Completion: 2022-11-12
• Study Completion: 2023-01-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Clinical diagnosis of Alzheimer's Disease Age more than 18

Exclusion Criteria

Life expectancy <1 year Prolonged cardiac arrest before VA-ECMO therapy (>60 min) Iatrogenic myocardial infarction secondary to a percutaneous coronary intervention VA-ECMO implanted in another center before admission

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Death	Not application	-
Survival	Not application	-

Primary Outcome Measures

Name	Time	Method
Survival rate	1 month	Survival information from ICU entry to ICU exit

Trial Locations

Locations (1)

Genglong Liu; 🇨🇳 Guangzhou, State..., China